Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Department of Internal Medicine and Liver Research Institute, Seoul National University, Seoul, South Korea.
Helicobacter. 2023 Aug;28(4):e12969. doi: 10.1111/hel.12969. Epub 2023 Mar 22.
The association between Helicobacter pylori (HP) infection and coronary heart disease (CHD) is controversial. This study aimed to investigate the effect of H. pylori eradication on CHD, especially in terms of age and sex.
From May 2003 to March 2022, 4765 subjects with H. pylori infection and without CHD (median follow-up: 51 months) were prospectively enrolled. The participants were categorized into two groups: H. pylori eradication and H. pylori non-eradication. After propensity-score matching (PSM), the effect of H. pylori eradication on CHD was analyzed using Cox proportional hazards.
There were no significant differences in age, sex, alcohol consumption, smoking habits, history of diabetes, hypertension, and dyslipidemia, and aspirin intake between the eradication and non-eradication groups (3783 vs. 982) before and after PSM. Multivariate analysis after PSM showed that H. pylori eradication (HR: 0.489, CI: 0.314-0.761, p = .002), age (HR: 1.027, CI: 1.007-1.047, p = .007), hypertension (HR: 2.133, CI: 1.337-3.404, p = 001), dyslipidemia (HR: 1.758, CI: 1.086-2.848, p = .022), and aspirin intake (HR: 2.508, CI: 1.566-4.017, p < .001) were associated with CHD development. H. pylori eradication prevented CHD in males ≤65 years (HR: 0.133, CI: 0.039-0.455, p = .001), but not in those aged >65 years (p = .078) (p for interaction = .022). In contrast, females aged >65 years (HR: 0.260, CI: 0.110-0.615, p = .002) were protected by H. pylori eradication and not those ≤65 years (p = .485) (p for interaction = .003). This preventive effect increased more after PSM, particularly in males ≤65 years and females >65 years.
H. pylori eradication prevented CHD and this effect was different depending on age and sex.
幽门螺杆菌(HP)感染与冠心病(CHD)之间的关联存在争议。本研究旨在探讨 HP 根除对 CHD 的影响,特别是在年龄和性别方面。
从 2003 年 5 月至 2022 年 3 月,前瞻性纳入了 4765 例 HP 感染且无 CHD 的受试者(中位随访:51 个月)。将参与者分为两组:HP 根除组和 HP 未根除组。在进行倾向评分匹配(PSM)后,使用 Cox 比例风险分析 HP 根除对 CHD 的影响。
在 PSM 前后,根除组和未根除组在年龄、性别、饮酒习惯、吸烟习惯、糖尿病、高血压、血脂异常和阿司匹林摄入史方面均无显著差异(3783 例 vs. 982 例)。PSM 后多变量分析显示,HP 根除(HR:0.489,CI:0.314-0.761,p = 0.002)、年龄(HR:1.027,CI:1.007-1.047,p = 0.007)、高血压(HR:2.133,CI:1.337-3.404,p = 001)、血脂异常(HR:1.758,CI:1.086-2.848,p = 0.022)和阿司匹林摄入(HR:2.508,CI:1.566-4.017,p < 0.001)与 CHD 发生相关。HP 根除可预防男性≤65 岁(HR:0.133,CI:0.039-0.455,p = 0.001)但不能预防男性>65 岁(p = 0.078)(p 交互 = 0.022)的 CHD。相反,女性>65 岁(HR:0.260,CI:0.110-0.615,p = 0.002)HP 根除可预防 CHD,而女性≤65 岁(p = 0.485)(p 交互 = 0.003)则不能预防 CHD。这种预防作用在 PSM 后增加更多,尤其是在男性≤65 岁和女性>65 岁的人群中。
HP 根除可预防 CHD,其效果因年龄和性别而异。